<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05122715</url>
  </required_header>
  <id_info>
    <org_study_id>215514655</org_study_id>
    <nct_id>NCT05122715</nct_id>
  </id_info>
  <brief_title>Demonstration Of A Next Generation PET CT System</brief_title>
  <official_title>Demonstration Of A Next Generation PET CT System (OMNI dBGO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intent of this evaluation is to obtain user feedback on device performance, user&#xD;
      preference, image quality, workflow, and new device features, a necessary part of product&#xD;
      development. This study will also help to inform protocol development in reducing both scan&#xD;
      time and/or radiologic tracer dose. The goal of this study is to collect a library of image&#xD;
      data from the hybrid PET/CT system to be used for evaluation and optimization of the image&#xD;
      quality of the system in a clinical setting and as comparison with the standard of care&#xD;
      hybrid PET/CT system, Discovery MI 25m (DMI5R).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 9, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation- Likert Scale</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The primary endpoints of this study are completed image evaluation using a 1 point Likert Scale of the OMNI PET/CT system including analysis, reading, and scoring utilizing a Likert Scale, by three (3) qualified Nuclear Medicine physicians.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Data Collection</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>PET/CT Image collection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Oncology</condition>
  <arm_group>
    <arm_group_label>OMNI PET/CT scan first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DMI PET/CT scan first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Additional PET/CT Scan</intervention_name>
    <description>The subject will undergo two PET/CT scans, one on the DMI scanner and one on the OMNI scanner.</description>
    <arm_group_label>DMI PET/CT scan first</arm_group_label>
    <arm_group_label>OMNI PET/CT scan first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult, who is at least 18 years of age;&#xD;
&#xD;
          2. A clinical indication for PET/CT examination according to current clinical practice&#xD;
             standards;&#xD;
&#xD;
          3. Able and willing to provide informed consent for participation in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diabetic patient with a glucose level â‰¥ 150 mg/dl at the time of the exam (for FDG)&#xD;
             or,&#xD;
&#xD;
          2. Known to be pregnant or breastfeeding (the investigational site will follow their&#xD;
             standard practice of verifying for women of childbearing age. No study specific&#xD;
             pregnancy test will be performed for this study); or,&#xD;
&#xD;
          3. Previously enrolled in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie L Karwedsky</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie L Karwedsky</last_name>
    <phone>262-443-7008</phone>
    <email>stephanie.karwedsky@ge.com</email>
  </overall_contact>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 14, 2021</last_update_submitted>
  <last_update_submitted_qc>November 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

